A member of the medical staff shows a used sample container at a test centre for coronavirus disease COVID-19 at Havelhoehe community hospital in Berlin, Germany, April 6. REUTERS/Fabrizio Bensch -/File Photo
Aug 28 (Reuters) - Gilead Inc said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.
The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness.
Comments
Leave a Comment